The Center for Innovation in Global Health Technologies (CIGHT) within the McCormick School of Engineering and the Feinberg School of Medicine's Robert J. Havey, MD Institute for Global Health recognizes the multidimensional complexity of the global healthcare arena. Working in alliance with corporate, not-for-profit, and education partners, CIGHT seeks not merely to develop, but bring to market comprehensive, context-appropriate healthcare solutions that integrate seamlessly with the lives of patients and medical practitioners in the developing world.
DASH (Diagnostic Analyzer for Specific Hybridization)
Developed by the Center for Innovation in Global Health Technologies (CIGHT), DASH is a new,highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes received a $21.3 million grant from the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative.
The point-of-care technology is being commercialized by Northwestern spinoff company Minute Molecular Diagnostics, which will use the NIH grant to ramp up production to one million test cartridges per month.